| Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis. | |
| | |
MedLine Citation:
|
PMID: 1788834 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Impaired fibrinolysis due to high plasminogen activator inhibitor levels is present in patients with a variety of thrombotic diseases. Plasminogen activator inhibitor levels correlate with triglyceride levels and are elevated in patients with hypertriglyceridemia. Treatment of asymptomatic hypertriglyceridemic patients with diet or medication results in improvement of fibrinolytic parameters. To determine if similar improvements in fibrinolysis occur during treatment of hypertriglyceridemia in patients with a history of venous thrombosis and impaired fibrinolysis due to high plasminogen activator inhibitor levels, 5 patients were given gemfibrozil. Triglyceride levels and fibrinolytic response to venous occlusion were determined before and after 30 days of treatment. Gemfibrozil therapy resulted in a predictable decrease in triglyceride levels in all patients, a reduction that was statistically significant (p = 0.04). There was no significant change in fibrinolytic variables during gemfibrozil therapy. Independent factors appear to control the plasminogen activator inhibitor and triglyceride levels in patients with a history of venous thrombosis. |
| | |
Authors:
|
W D Haire |
Related Documents
:
|
6720724 - Unrecognized pulmonary embolism presenting as disseminated intravascular coagulation. 7378294 - Serum inhibitors of myelopoiesis. 1152504 - The hemostatic mechanism after open-heart surgery. i. studies on plasma coagulation fac... 6299654 - Angiotensin-converting enzyme in human adult respiratory distress syndrome. 17449234 - Systemic inflammation and systemic oxidative stress in patients with acute exacerbation... 23056774 - Acute hemorrhagic edema of infancy; a report of five iranian infants and review of the ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Thrombosis research Volume: 64 ISSN: 0049-3848 ISO Abbreviation: Thromb. Res. Publication Date: 1991 Nov |
Date Detail:
|
Created Date: 1992-03-20 Completed Date: 1992-03-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0326377 Medline TA: Thromb Res Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 493-501 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine, University of Nebraska Medical Center, Omaha. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cholesterol
/
blood Fibrinolysis / drug effects Gemfibrozil / pharmacology*, therapeutic use Humans Hypertriglyceridemia / blood, complications, drug therapy* Plasminogen Inactivators / analysis* Thrombophlebitis / complications* Tissue Plasminogen Activator / analysis Triglycerides / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Plasminogen Inactivators; 0/Triglycerides; 25812-30-0/Gemfibrozil; 57-88-5/Cholesterol; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Circadian variations of platelet aggregability and fibrinolytic activity in patients with ischemic s...
Next Document: Temperature-dependence of LDL binding and activation of human platelets.